„Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy”. Drugs. 34 (1): 50–97. . doi:10.2165/00003495-198734010-00003. PMID3308412.
„Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes”. Current Diabetes Reviews. 4 (1): 55–62. . doi:10.2174/157339908783502343. PMID18220696.
„Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice”. European Journal of Pharmacology. 670 (2–3): 464–70. . doi:10.1016/j.ejphar.2011.09.026. PMID21946102.
„Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy”. Drugs. 34 (1): 50–97. . doi:10.2165/00003495-198734010-00003. PMID3308412.
„Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes”. Current Diabetes Reviews. 4 (1): 55–62. . doi:10.2174/157339908783502343. PMID18220696.
„Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice”. European Journal of Pharmacology. 670 (2–3): 464–70. . doi:10.1016/j.ejphar.2011.09.026. PMID21946102.